Please login to the form below

Not currently logged in
Email:
Password:

IDF appoints new CEO

Petra Wilson to head global diabetes organisation

IDF CEOThe International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its new CEO.

Dr Wilson joins the global organisation, which represents more than 200 diabetes associations, from network and IT firm Cisco where she was senior director of the European health and care business.

She gained experience in this role working with the World Heath Organization, the European Commission and governments on the use of communications technologies in healthcare systems.

Her other healthcare roles include serving as director of the European Health Management Association and as scientific officer for the European Commission.

This career follows a background in law, with Dr Wilson a former lecturer in law at the University of Nottingham having completed a doctorate at Oxford University in public health law.

She said: “Diabetes is one of the most pressing health challenges globally, which demands that people, organisations, communities and nations work together to create a better future for those affected by the disease. IDF has a deservedly high reputation as a forthright advocate for people with diabetes, and I look forward to being part of such a dynamic global movement.”

8th November 2013

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Tonic Life Communications

We are the go-to agency for both established brands and ambitious startups. Here’s why: Deep experience. In the life sciences...

Latest intelligence

Online Physician Communities
Review: diabetes tweetchat
Some of the key points from the recent #M3diabetes tweetchat held by PMLiVE and M3 Europe...
access denied
Sales reps struggle to access doctors
Doctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information...
Online Physician Communities
Research finds doctors are optimistic about new diabetes drugs but concerned over rationing
New data from M3 Global Research shows that clinicians buy in to the effectiveness of new diabetes therapies. However, they are concerned about rationing and believe that more resources are...